miglitol vs ranitidine

According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.

Side-by-side comparison of miglitol and ranitidine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

minor Known Drug Interaction

Other healthy volunteer studies have demonstrated that miglitol may significantly reduce the bioavailability of ranitidine and propranolol by 60% and 40%, respectively.

Drug Class
miglitol Alpha-Glucosidase Inhibitor
ranitidine H2 Receptor Antagonist
Type
miglitol Prescription
ranitidine Over-the-Counter
Summary
miglitol

Miglitol (Glyset) helps control blood sugar in adults with type 2 diabetes. It should be used with diet and exercise.

ranitidine

Ranitidine (Zantac) helps reduce stomach acid. It can relieve heartburn and sour stomach.

What It Treats
miglitol

Miglitol treats type 2 diabetes. It helps lower your blood sugar levels after meals. You should use it along with a healthy diet and regular exercise to manage your diabetes.

ranitidine

This medicine treats heartburn caused by acid indigestion and sour stomach. You can also take it to prevent heartburn. It can prevent heartburn caused by eating or drinking certain foods and drinks.

How It Works
miglitol

Miglitol slows down the digestion of carbohydrates. This helps to prevent a large rise in blood sugar after you eat. It works in your gut to block certain enzymes.

ranitidine

Ranitidine is an H2 receptor antagonist. It works by blocking histamine. Blocking histamine reduces the amount of acid your stomach makes.

Common Side Effects
miglitol
  • Gas
  • Diarrhea
  • Abdominal pain
ranitidine
  • Headache
FAERS Reports
miglitol
  • Hypoglycaemia 67
  • Hepatic Function Abnormal 46
  • Decreased Appetite 39
  • Diarrhoea 37
  • Renal Impairment 37
ranitidine
  • Breast Cancer 24,853
  • Prostate Cancer 22,252
  • Colorectal Cancer 17,674
  • Bladder Cancer 16,746
  • Renal Cancer 16,278
Serious Warnings
miglitol

No specific warnings noted.

ranitidine

No specific warnings noted.

Pregnancy
miglitol

There is not enough information about the safety of miglitol during pregnancy or breastfeeding. Talk to your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.

ranitidine

No pregnancy information available.

Also Compare, Nearby Drugs

How to Read This miglitol vs ranitidine Comparison

miglitol is classified in the Alpha-Glucosidase Inhibitor drug class, while ranitidine sits within the H2 Receptor Antagonist class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, miglitol has 226 submissions while ranitidine has 97,803. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to miglitol reduces how much ranitidine your body absorbs, which can make the medicine less effective.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for miglitol or ranitidine.

Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.